HIV Gene Therapy

Researchers Use Gene Therapy To Protect Human Cells from HIV

Published in AIDS Weekly, May 5th, 1997

Scientists have successfully used gene therapy in the laboratory to produce human immune (CD4⁺) cells with resistance to repeated challenges by HIV over a prolonged period.

The data was reported in the May 1997 edition of the Journal of Virology. The more than year-long study showed that CD4⁺ monocyte cells, which are normally sensitive to HIV, are protected from HIV infection when treated with this new form of gene therapy, known as genetic antisense.

The study was conducted by Enzo Biochem, New York, New York, and researchers including Jeffrey Laurence, M.D., New York Hospital-Cornell University Medical College. They reported...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-05-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry